| scholarly article | Q13442814 |
| P50 | author | Sarah Radecke | Q121281024 |
| Frank Radecke | Q121281057 | ||
| P2093 | author name string | Klaus Schwarz | |
| P2860 | cites work | An unbiased genome-wide analysis of zinc-finger nuclease specificity | Q39493921 |
| Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations | Q39506695 | ||
| Parameters of oligonucleotide-mediated gene modification in mouse ES cells | Q39821715 | ||
| Targeted chromosomal gene modification in human cells by single-stranded oligodeoxynucleotides in the presence of a DNA double-strand break | Q40244305 | ||
| CRISPR-Cas9 gene repair of hematopoietic stem cells from patients with X-linked chronic granulomatous disease. | Q40375767 | ||
| Physical incorporation of a single-stranded oligodeoxynucleotide during targeted repair of a human chromosomal locus | Q40377055 | ||
| Unmodified oligodeoxynucleotides require single-strandedness to induce targeted repair of a chromosomal EGFP gene | Q40508717 | ||
| Molecular analysis of T lymphocyte-directed gene therapy for adenosine deaminase deficiency: long-term expression in vivo of genes introduced with a retroviral vector | Q41192415 | ||
| Specificity and sensitivity of polymerase chain reaction (PCR) in comparison with other methods for the detection of mycoplasma contamination in cell lines | Q41533181 | ||
| Persistence and expression of the adenosine deaminase gene for 12 years and immune reaction to gene transfer components: long-term results of the first clinical gene therapy trial. | Q44232574 | ||
| Polyclonal long-term repopulating stem cell clones in a primate model | Q45855127 | ||
| Comprehensive genomic access to vector integration in clinical gene therapy | Q45855528 | ||
| A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency | Q45857796 | ||
| Genomic sequence correction by single-stranded DNA oligonucleotides: role of DNA synthesis and chemical modifications of the oligonucleotide ends | Q46605440 | ||
| DNA replication and transcription direct a DNA strand bias in the process of targeted gene repair in mammalian cells. | Q50798271 | ||
| DNA Breaks and End Resection Measured Genome-wide by End Sequencing. | Q51603184 | ||
| Site-directed mutagenesis: generation of an extracistronic mutation in bacteriophage Q beta RNA. | Q53919895 | ||
| Zinc-finger nuclease-induced gene repair with oligodeoxynucleotides: wanted and unwanted target locus modifications | Q24630071 | ||
| Characterization of individual polynucleotide molecules using a membrane channel | Q24681325 | ||
| BLAT—The BLAST-Like Alignment Tool | Q24682492 | ||
| Gene therapy: progress and predictions | Q26772109 | ||
| WebLogo: A Sequence Logo Generator | Q27860646 | ||
| Fast gapped-read alignment with Bowtie 2 | Q27860699 | ||
| Genome editing. The new frontier of genome engineering with CRISPR-Cas9 | Q28252298 | ||
| Real-time DNA sequencing using detection of pyrophosphate release | Q28297219 | ||
| chromPlot: visualization of genomic data in chromosomal context | Q31092195 | ||
| Gene therapy for Wiskott-Aldrich syndrome--long-term efficacy and genotoxicity | Q33413888 | ||
| Insertional transformation of hematopoietic cells by self-inactivating lentiviral and gammaretroviral vectors | Q33713156 | ||
| Increased efficiency of oligonucleotide-mediated gene repair through slowing replication fork progression. | Q33850144 | ||
| Nanopores and nucleic acids: prospects for ultrarapid sequencing | Q33877052 | ||
| Continuous base identification for single-molecule nanopore DNA sequencing | Q34016957 | ||
| GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases | Q34454104 | ||
| Regulation of Gene Editing Activity Directed by Single-Stranded Oligonucleotides and CRISPR/Cas9 Systems | Q34479696 | ||
| Insertion sites in engrafted cells cluster within a limited repertoire of genomic areas after gammaretroviral vector gene therapy | Q35568549 | ||
| Cell-culture assays reveal the importance of retroviral vector design for insertional genotoxicity | Q35849232 | ||
| Improved Genome Editing Efficiency and Flexibility Using Modified Oligonucleotides with TALEN and CRISPR-Cas9 Nucleases | Q35938792 | ||
| Mechanism of gene repair open for discussion | Q36017654 | ||
| High-frequency genome editing using ssDNA oligonucleotides with zinc-finger nucleases | Q36744028 | ||
| Nucleotide-resolution DNA double-strand break mapping by next-generation sequencing | Q36834533 | ||
| Ultra-superovulation for the CRISPR-Cas9-mediated production of gene-knockout, single-amino-acid-substituted, and floxed mice. | Q37216828 | ||
| Gene therapy for primary adaptive immune deficiencies | Q37882129 | ||
| Oligonucleotide-directed gene-editing technology: mechanisms and future prospects. | Q37982821 | ||
| Genome engineering at the dawn of the golden age. | Q38108846 | ||
| Targeted gene repair in mammalian cells using chimeric RNA/DNA oligonucleotides and modified single-stranded vectors | Q38293639 | ||
| Gene therapy returns to centre stage | Q38607706 | ||
| Genome-wide translocation sequencing reveals mechanisms of chromosome breaks and rearrangements in B cells | Q38626707 | ||
| DSBCapture: in situ capture and sequencing of DNA breaks. | Q39489184 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 115-131 | |
| P577 | publication date | 2017-09-15 | |
| P1433 | published in | Molecular Therapy | Q15762400 |
| P1476 | title | Genome-wide Mapping of Off-Target Events in Single-Stranded Oligodeoxynucleotide-Mediated Gene Repair Experiments | |
| P478 | volume | 26 |
Search more.